Internal Medicine, Nephrology · San Antonio, TX
NPI
1154329720
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
215 N San Saba Ste 201
San Antonio, TX, 78207
Phone (210) 547-3430
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
1,920 services
Medicare patients, 2024
472
Average age 74
Drug cost, 2024
$1.6M
4,066 prescriptions
Company payments, 2025
$14K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Varshasb Broumand was code 99214 (office e&m - established), 703 times for 325 patients. In total Varshasb Broumand billed 1,920 services in 42 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 703 | 325 | $63.68 | $45K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 392 | 221 | $12.45 | $4,882 |
| 90960 ESRD Related Services (not dialysis) | Office | 187 | 34 | $259.72 | $49K |
| 90966 ESRD Related Services (not dialysis) | Office | 99 | 16 | $216.32 | $21K |
| 99215 Office E&M - Established | Office | 54 | 49 | $81.73 | $4,413 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 52 | 52 | $72.55 | $3,773 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 29 | $90.21 | $4,420 |
| 90961 ESRD Related Services (not dialysis) | Office | 38 | 20 | $210.58 | $8,002 |
| 99204 Office E&M - New | Office | 30 | 30 | $105.58 | $3,167 |
| 99205 Office E&M - New | Office | 27 | 27 | $165.19 | $4,460 |
| 36902 A-V Fistula PCI | Facility | 22 | 18 | $160.08 | $3,522 |
| 51798 Ultrasound - Nonspecific | Office | 21 | 21 | $7.18 | $151 |
| 99232 Hospital E&M - Subsequent | Facility | 21 | 13 | $59.96 | $1,259 |
| 36215 Angiography | Facility | 19 | 17 | $91.62 | $1,741 |
| 75710 Angiography | Facility | 19 | 17 | $62.17 | $1,181 |
By year: 2022 $188K for 1,717 services; 2023 $160K for 1,425 services; 2024 $166K for 1,920 services.
Medicare prescription drug claims, 2024
In 2024, the drug Varshasb Broumand prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 208 prescriptions and refills. In total Varshasb Broumand wrote 4,066 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 208 | 389 | 59 | $208K |
| Hydralazine Hcl Generic | 193 | 517 | 74 | $3,544 |
| Nifedipine Er Nifedipine | 159 | 427 | 53 | $4,338 |
| Furosemide Generic | 153 | 395 | 57 | $1,452 |
| Amlodipine Besylate Generic | 152 | 402 | 55 | $1,062 |
| Kerendia Finerenone | 144 | 267 | 37 | $173K |
| Rayaldee Calcifediol | 140 | 164 | 26 | $262K |
| Atorvastatin Calcium Generic | 128 | 369 | 51 | $1,066 |
| Sevelamer Carbonate Generic | 121 | 238 | 50 | $21K |
| Ozempic Semaglutide | 99 | 132 | 28 | $113K |
| Losartan Potassium Generic | 93 | 240 | 32 | $1,137 |
| Carvedilol Generic | 91 | 227 | 28 | $611 |
| Valsartan Generic | 91 | 257 | 33 | $2,164 |
| Tamsulosin Hcl Generic | 85 | 213 | 26 | $1,309 |
| Allopurinol Generic | 78 | 211 | 25 | $551 |
Brand drugs: - claims; generic drugs: 2,886 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Varshasb Broumand $14K ($14K in general payments such as food, travel and fees) from 22 companies. The largest payer was Akebia Therapeutics Inc with $6,368.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 14 | $6,368 |
| Outset Medical Inc OM | 8 | $5,153 |
| Amgen Inc. AMGN | 12 | $402 |
| OPKO Pharmaceuticals, LLC | 36 | $371 |
| Travere Therapeutics, Inc. TVTX | 5 | $200 |
| Fresenius USA Marketing, Inc. | 11 | $193 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $173 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $155 |
| Novo Nordisk Inc NVO | 6 | $146 |
| Calliditas Therapeutics US Inc. | 6 | $145 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.